OVARIAN CANCER MONTH ▲ Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)

OVARIAN CANCER MONTH

Last Updated: Sep 15, 2016

• In honor of Ovarian Cancer Awareness Month
  G Hurst, Cure today, Sepetember 2016
• Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.
  Geurts-Giele Willemina R R, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 9
• Finding all BRCA pathogenic mutation carriers: best practice models.
  Hoogerbrugge Nicoline et al. European journal of human genetics : EJHG 2016 Sep S19-26
• Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.
  Prodosmo Andrea, et al. Journal of experimental & clinical cancer research : CR 2016 0 (1) 135
• Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
  Lawrenson Kate, et al. Nature communications 2016 0 12675
• The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.
  Konopka Bozena, et al. Oncotarget 2016 9
• BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.
  Chun Danielle S et al. Familial cancer 2016 Sep
• Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer.
  Carron Juliana, et al. Medical oncology (Northwood, London, England) 2016 10 (10) 112
• Low-grade serous ovarian cancer: A review.
  Kaldawy Anis, et al. Gynecologic oncology 2016 8
• Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
  Hackmann Karl, et al. Breast cancer research and treatment 2016 8
• Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis.
  Xu Yue, et al. OncoTargets and therapy 2016 0 5225-33
• Causes of Cancer Death Among First-Degree Relatives in Japanese Families with Lynch Syndrome.
  Tanakaya Kohji et al. Anticancer research 2016 Apr 36(4) 1985-9
• High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
  Rashid Muhammad Usman, et al. BMC cancer 2016 0 (1) 673
• Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
  Pinto Pedro, et al. Breast cancer research and treatment 2016 8
• All women with ovarian cancer should be offered genetic testing – so why aren’t they? 
  E Smith, Science Blogs, August 17, 2016

• CDC Information (9)
• CDC-Authored Pub (7)

• Human (52)
• Pathogen (0)

• Human (1497)
• Pathogen (0)

• Human (226)
• Pathogen (0)

• Guidelines (11)
• Tier Table (4)
• Synthesis (14)

• Huamn (112)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB